139 related articles for article (PubMed ID: 26633557)
1. FAT4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract][Full Text] [Related]
2. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract][Full Text] [Related]
3. Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1.
Gao J; Zhao C; Liu Q; Hou X; Li S; Xing X; Yang C; Luo Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):317. PubMed ID: 30547803
[TBL] [Abstract][Full Text] [Related]
4. Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation.
Radulescu S; Ridgway RA; Cordero J; Athineos D; Salgueiro P; Poulsom R; Neumann J; Jung A; Patel S; Woodgett J; Barker N; Pritchard DM; Oien K; Sansom OJ
Oncogene; 2013 Apr; 32(16):2048-57. PubMed ID: 22665058
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4.
Tian L; Shen D; Li X; Shan X; Wang X; Yan Q; Liu J
Oncotarget; 2016 Jan; 7(2):1619-32. PubMed ID: 26636541
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107.
Teng R; Hu Y; Zhou J; Seifer B; Chen Y; Shen J; Wang L
PLoS One; 2015; 10(12):e0143716. PubMed ID: 26636340
[TBL] [Abstract][Full Text] [Related]
8. Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.
Ragni CV; Diguet N; Le Garrec JF; Novotova M; Resende TP; Pop S; Charon N; Guillemot L; Kitasato L; Badouel C; Dufour A; Olivo-Marin JC; Trouvé A; McNeill H; Meilhac SM
Nat Commun; 2017 Feb; 8():14582. PubMed ID: 28239148
[TBL] [Abstract][Full Text] [Related]
9. PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial-Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells.
Chen HN; Yuan K; Xie N; Wang K; Huang Z; Chen Y; Dou Q; Wu M; Nice EC; Zhou ZG; Huang C
Cancer Res; 2016 Mar; 76(5):1122-34. PubMed ID: 26701804
[TBL] [Abstract][Full Text] [Related]
10. Reduced proliferation and increased apoptosis of the SGC‑7901 gastric cancer cell line on exposure to GDC‑0449.
Wu C; Cheng J; Hu S; Deng R; Muangu YW; Shi L; Wu K; Zhang P; Chang W; Wang G; Tao K
Mol Med Rep; 2016 Feb; 13(2):1434-40. PubMed ID: 26676867
[TBL] [Abstract][Full Text] [Related]
11. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
12. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
13. History and progression of Fat cadherins in health and disease.
Zhang X; Liu J; Liang X; Chen J; Hong J; Li L; He Q; Cai X
Onco Targets Ther; 2016; 9():7337-7343. PubMed ID: 27942226
[TBL] [Abstract][Full Text] [Related]
14. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
Wang L; Li K; Wang C; Shi X; Yang H
Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
[TBL] [Abstract][Full Text] [Related]
15. FAT4-USP51 complex regulates the proliferation and invasion of endometrial cancer via Hippo pathway.
Che X; Jian F; Jia N; Zheng Y; Jiang Y; Feng W
Am J Transl Res; 2019; 11(5):2784-2800. PubMed ID: 31217854
[TBL] [Abstract][Full Text] [Related]
16. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract][Full Text] [Related]
17. A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.
Luo Q; Vögeli TA
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33092083
[TBL] [Abstract][Full Text] [Related]
18. BTK Has Potential to Be a Prognostic Factor for Lung Adenocarcinoma and an Indicator for Tumor Microenvironment Remodeling: A Study Based on TCGA Data Mining.
Bi KW; Wei XG; Qin XX; Li B
Front Oncol; 2020; 10():424. PubMed ID: 32351880
[TBL] [Abstract][Full Text] [Related]
19. Gene mutation profiling in Chinese colorectal cancer patients and its association with clinicopathological characteristics and prognosis.
Ye ZL; Qiu MZ; Tang T; Wang F; Zhou YX; Lei MJ; Guan WL; He CY
Cancer Med; 2020 Jan; 9(2):745-756. PubMed ID: 31782259
[TBL] [Abstract][Full Text] [Related]
20. Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors.
Pan S; Zhan Y; Chen X; Wu B; Liu B
Front Oncol; 2019; 9():1101. PubMed ID: 31737562
[No Abstract] [Full Text] [Related]
[Next] [New Search]